Journalist Matt Schiavenza offers advice to companies looking for ways to get a foothold in Cuba’s emerging domestic market. Businesses face layers of bureaucratic red tape, censorship concerns and meager paychecks. However, the island nation boasts a highly educated workforce that is already proving valuable in the medical and IT fields. For pharmaceutical companies, Cuba could emerge a prime research spot, while tech companies have a large workforce already in place. getAbstract recommends this analysis to business leaders interested in the Cuba’s unique market.
In this summary, you will learn
- Why Cuba’s highly educated workforce could benefit the medical field and IT companies,
- Why a promising lung cancer vaccine could signal an opening for pharmaceutical companies, and
- Why the country could become an IT hub.
About the Author
Matt Schiavenza is a writer and editor based in New York. His articles have been published in The Atlantic, the Daily Beast, Fortune and the New Republic.
Comment on this summary
Customers who read this summary also read
Jordan Robertson et al.
Bloomberg Businessweek , 2017
Joakim Wernberg and Jacob Dexe
Wilfried Martens Center for European Studies, 2016